Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis

ASR Pang, T Dinesh, NYL Pang, V Dinesh, KYL Pang… - Molecules, 2024 - mdpi.com
Atherosclerosis continues to be a leading cause of morbidity and mortality globally. The
precise evaluation of the extent of an atherosclerotic plaque is essential for forecasting its …

Application of nanotechnology for diagnosis and drug delivery in atherosclerosis: A new horizon of treatment

CR Lankala, M Yasir, A Ishak, M Mekhail… - Current Problems in …, 2023 - Elsevier
Cardiovascular diseases are the leading cause of death worldwide, with atherosclerosis
being a prominent risk factor for their development. The current diagnostic criteria for …

Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology

SA Wickline, AM Neubauer, P Winter… - … , and vascular biology, 2006 - Am Heart Assoc
The role of nanotechnology in cardiovascular diagnosis is expanding rapidly. The goal of
this brief review is to illustrate selected examples of nanosystems that have been applied to …

Recent progress in the detection and treatment of atherosclerosis by nanoparticles

L Chen, Z Jiang, OU Akakuru, L Yang, J Li, S Ma… - Materials Today …, 2020 - Elsevier
Cardiovascular diseases (CVDs) have high mortality and morbidity in the US and presently
rank as one of the leading causes of death. Atherosclerosis (AS) acts as one of the CVDs …

Nanomaterials responsive to endogenous biomarkers for cardiovascular disease theranostics

C Wei, Z Jiang, C Li, P Li, Q Fu - Advanced Functional Materials, 2023 - Wiley Online Library
Cardiovascular disease (CVD) is the number one cause of death worldwide, which propels
the development of advanced technologies for CVD diagnosis and treatment. Biomarker …

Animal models used in the research of nanoparticles for cardiovascular diseases

C Dong, A Ma, L Shang - Journal of Nanoparticle Research, 2021 - Springer
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity worldwide.
Tremendous progress has been made in the prevention and treatment of CVD; however …

Cardiovascular nanomedicine: the route ahead

M Iafisco, A Alogna, M Miragoli, D Catalucci - Nanomedicine, 2019 - Taylor & Francis
Heart failure, coronary cardiac disease, myocardial infarction and inflammatory heart
disease, along with other cardiovascular diseases (CVDs), account for the widest health …

The application of nanomaterials in cardiovascular diseases: A review on drugs and devices

SM Dizaj, AA Rad, N Safaei… - … of Pharmacy & …, 2019 - journals.library.ualberta.ca
Cardiovascular diseases (CVDs) are still one of the main causes of death. In recent years,
nanotechnology has offered new materials and strategies for more effective and safe …

Atherosclerosis and nanotechnology: diagnostic and therapeutic applications

JD Kratz, A Chaddha, S Bhattacharjee… - … drugs and therapy, 2016 - Springer
Over the past several decades, tremendous advances have been made in the
understanding, diagnosis, and treatment of coronary artery disease (CAD). However, with …

Nanomedicine applied to cardiovascular diseases: latest developments

VM Martín Giménez, DE Kassuha… - Therapeutic …, 2017 - journals.sagepub.com
Cardiovascular diseases are a major cause of disability and they are currently responsible
for a significant number of deaths in a large percentage of the world population. A large …